Gofen & Glossberg’s BriaCell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCTX
Gofen & Glossberg's BCTX Position: Q4 2021 in Review
Gofen & Glossberg sold out of BriaCell Therapeutics (BCTX) in Q4 2021, closing a stake of 67 shares — an estimated $81K sold.
Gofen & Glossberg first reported a position in BCTX in Q3 2021 and held it in 1 quarter. The position peaked at $81K in Q3 2021. 18 funds tracked by Wall St. Rank hold BCTX as of Q4 2021.
- Gofen & Glossberg reported no remaining BriaCell Therapeutics position as of Q4 2021 after selling out during the quarter.
- Gofen & Glossberg sold 67 BriaCell Therapeutics shares in Q4 2021, an estimated $81K.
- Gofen & Glossberg first reported a position in BriaCell Therapeutics in Q3 2021 and held it in 1 quarter.
- Gofen & Glossberg's BriaCell Therapeutics position peaked at $81K in Q3 2021.
- 18 funds tracked by Wall St. Rank held BriaCell Therapeutics as of Q4 2021.
Based on Gofen & Glossberg's 13F filing for Q4 2021, filed 25 Jan 2022.